{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:07:40Z","timestamp":1793041660861,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI21\/00691"],"award-info":[{"award-number":["PI21\/00691"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI22\/01770"],"award-info":[{"award-number":["PI22\/01770"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1053\/j.gastro.2025.08.020","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:56:28Z","timestamp":1762782988000},"page":"385-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The ANTICIPATE-NASH Models Stratify Better the Risk of Clinical Events Than Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients With Advanced Chronic Liver Disease"],"prefix":"10.1053","volume":"170","author":[{"given":"Laia","family":"Aceituno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ba\u00f1ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f2nica","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Rivera-Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Sabiote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calogero","family":"Camm\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacinta","family":"Ciancimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Pennisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Tulone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mang M.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Billin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Petta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Peric\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan G.","family":"Abraldes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Genesc\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2025.08.020_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41512-019-0060-y","article-title":"Methodological standards for the development and evaluation of clinical prediction rules: a review of the literature","volume":"3","author":"Cowley","year":"2019","journal-title":"Diagn Progn Res"},{"key":"10.1053\/j.gastro.2025.08.020_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/1471-0528.14170","article-title":"Key steps and common pitfalls in developing and validating risk models","volume":"124","author":"Wynants","year":"2017","journal-title":"BJOG"},{"key":"10.1053\/j.gastro.2025.08.020_bib3","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.020_bib4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib5","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2025.08.020_bib6","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2025.08.020_bib7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jhep.2020.06.025","article-title":"Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials","volume":"73","author":"Davison","year":"2020","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.020_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.020_bib10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jhep.2024.05.033","article-title":"Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD","volume":"81","author":"Paternostro","year":"2024","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII\u2014renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib12","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jhep.2022.07.004","article-title":"Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design","volume":"77","author":"Allen","year":"2022","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib13","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/hep.28824","article-title":"Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the \u201cAnticipate\u201d study","volume":"64","author":"Abraldes","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.020_bib14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.14309\/ajg.0000000000000994","article-title":"Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease","volume":"116","author":"Pons","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.020_bib15","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1002\/hep4.2091","article-title":"Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: validation of ANTICIPATE models and development of a lab-based model","volume":"6","author":"Rabiee","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2025.08.020_bib16","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.cgh.2023.08.004","article-title":"Point-of-care non-invasive prediction of liver-related events in patients with NAFLD","volume":"22","author":"Pons","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib17","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.cgh.2020.06.045","article-title":"Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease","volume":"19","author":"Petta","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","article-title":"Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials","volume":"73","author":"Harrison","year":"2020","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib19","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2018.07.006","article-title":"Simtuzumab Is Ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis","volume":"155","author":"Harrison","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.08.020_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/M22-0844","article-title":"Assessing performance and clinical usefulness in prediction models with survival outcomes: practical guidance for Cox proportional hazards models","volume":"176","author":"McLernon","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2025.08.020_bib21","first-page":"1","article-title":"Non-invasive testing in metabolic dysfunction-associated steatotic liver disease","volume":"11","author":"Dawod","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1053\/j.gastro.2025.08.020_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/liv.14669","article-title":"Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review","volume":"41","author":"Lee","year":"2021","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2025.08.020_bib23","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cgh.2022.06.013","article-title":"AGILE 3+ score for the diagnosis of advanced fibrosis and for predicting liver-related events in NAFLD","volume":"21","author":"Pennisi","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2022.10.034","article-title":"Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores","volume":"78","author":"Sanyal","year":"2023","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib25","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.cgh.2020.06.070","article-title":"Enhanced liver fibrosis score can be used to predict liver-related events in patients with nonalcoholic steatohepatitis and compensated cirrhosis","volume":"19","author":"Are","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib26","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jhep.2011.01.051","article-title":"Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study","volume":"55","author":"Robic","year":"2011","journal-title":"J Hepato"},{"key":"10.1053\/j.gastro.2025.08.020_bib27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S2468-1253(23)00141-3","article-title":"Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis","volume":"8","author":"M\u00f3zes","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib28","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jama.2024.1447","article-title":"Vibration-controlled transient elastography scores to predict liver-related events in steatotic liver disease","volume":"331","author":"Lin","year":"2024","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2025.08.020_bib29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2024.05.008","article-title":"Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD","volume":"81","author":"Gawrieh","year":"2024","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/hep4.1154","article-title":"Liver stiffness measurement predicted liver-related events and all-cause mortality: a systematic review and nonlinear dose-response meta-analysis","volume":"2","author":"Wang","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2025.08.020_bib31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12072-019-09952-5","article-title":"The prognostic role of liver stiffness in patients with chronic liver disease: a systematic review and dose-response meta-analysis","volume":"13","author":"Shen","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2025.08.020_bib32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/HEP.0000000000001183","article-title":"Validation and expansion of Baveno VII criteria for cACLD and CSPH based on liver stiffness and platelet count: correlation with risk of hepatic decompensation and death","volume":"82","author":"Vutien","year":"2025","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.020_bib33","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/apt.17699","article-title":"Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: a competing risk analysis","volume":"58","author":"Lin","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2025.08.020_bib34","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/liv.15632","article-title":"Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII","volume":"43","author":"Song","year":"2023","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2025.08.020_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3350\/cmh.2022.0181","article-title":"Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients","volume":"29","author":"Wong","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib36","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.14309\/ajg.0000000000001887","article-title":"A combined Baveno VII and spleen stiffness algorithm to improve the noninvasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease","volume":"117","author":"Dajti","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.08.020_bib37","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.cgh.2022.09.032","article-title":"The sequential application of Baveno VII criteria and VITRO score improves diagnosis of clinically significant portal hypertension","volume":"21","author":"Jachs","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.08.020_bib38","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/hep.31576","article-title":"ABIDE: an accurate predictive model of liver decompensation in patients with nonalcoholic fatty liver-related cirrhosis","volume":"73","author":"Calzadilla-Bertot","year":"2021","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.020_bib39","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/HEP.0000000000000356","article-title":"Predicting liver-related events in NAFLD: a predictive model","volume":"78","author":"Calzadilla-Bertot","year":"2023","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.08.020_bib40","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/hep.32204","article-title":"Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis","volume":"75","author":"Sanyal","year":"2022","journal-title":"Hepatology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525059050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525059050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T13:56:58Z","timestamp":1779717418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508525059050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0016508525059050"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2025.08.020","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ANTICIPATE-NASH Models Stratify Better the Risk of Clinical Events Than Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients With Advanced Chronic Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2025.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}